Phase I study of camrelizumab in patients with advanced solid tumors

被引：0
|
作者：
Yuxiang Ma
Jiaxin Cao
Yang Zhang
Qianwen Liu
Wenfeng Fang
Yunpeng Yang
Yuanyuan Zhao
Qing Yang
Hongyun Zhao
Li Zhang
机构：
[1] Sun Yat-sen University Cancer Center,Department of Clinical Research
[2] State Key Laboratory of Oncology in South China,Department of Medical Oncology
[3] Collaborative Innovation Center for Cancer Medicine,undefined
[4] Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy,undefined
[5] Sun Yat-sen University Cancer Center,undefined
[6] State Key Laboratory of Oncology in South China,undefined
[7] Collaborative Innovation Center for Cancer Medicine,undefined
[8] Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy,undefined
[9] Jiangsu Hengrui Medicine Co. Ltd,undefined
来源：
Signal Transduction and Targeted Therapy | / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] A phase I study of Triapine® in combination with doxorubicin in patients with advanced solid tumors
    William R. Schelman
    Sherry Morgan-Meadows
    Rebecca Marnocha
    Fred Lee
    Jens Eickhoff
    Wei Huang
    Marcia Pomplun
    Zhisheng Jiang
    Dona Alberti
    Jill M. Kolesar
    Percy Ivy
    George Wilding
    Anne M. Traynor
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 1147 - 1156
  • [32] Docetaxel and ifosfamide in patients with advanced solid tumors: Results of a phase I study
    Pronk, LC
    Schrijvers, D
    Schellens, JHM
    de Bruijn, EA
    Planting, AST
    Locci-Tonelli, D
    Groult, V
    Verweij, J
    van Oosterom, AT
    SEMINARS IN ONCOLOGY, 1998, 25 (01) : 23 - 28
  • [33] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Plummer, Ruth
    Madi, Ayman
    Jeffels, Melinda
    Richly, Heike
    Nokay, Bahar
    Rubin, Stephen
    Ball, Howard A.
    Weller, Steve
    Botbyl, Jeffrey
    Gibson, Diana M.
    Scheulen, Max E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 93 - 101
  • [34] Phase I study of sapacitabine and seliciclib in patients with advanced solid tumors.
    Tolaney, Sara M.
    Hilton, John Frederick
    Cleary, James M.
    Gandhi, Leena
    Kwak, Eunice Lee
    Clark, Jeffrey W.
    Wolanski, Andrew
    Bell, Tracy Demeo
    Rodig, Scott J.
    Chiao, Judy H.
    Blake, David
    Shapiro, Geoffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [35] A phase I study of bizelesin (NSC 615291) in patients with advanced solid tumors
    Pitot, HC
    Reid, JM
    Sloan, JA
    Ames, MM
    Adjei, AA
    Rubin, J
    Bagniewski, PG
    Atherton, P
    Rayson, D
    Goldberg, RM
    Erlichman, C
    CLINICAL CANCER RESEARCH, 2002, 8 (03) : 712 - 717
  • [36] A phase I QTc study of tivozanib in patients with advanced solid tumors.
    Chadha, Manpreet Kaur
    Infante, Jeffrey R.
    Cotreau, Monette M.
    Jacobson, Lindsey
    Strahs, Andrew Louis
    Slichenmyer, William
    Vargo, Dennis
    Moore, Kathleen N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [37] A phase I and pharmacokinetic study of losoxantrone and paclitaxel in patients with advanced solid tumors
    Diab, SG
    Baker, SD
    Joshi, A
    Burris, HA
    Cobb, PW
    Villalona-Calero, RA
    Eckhardt, SG
    Weiss, GR
    Rodriguez, GI
    Drengler, R
    Kraynak, M
    Hammond, L
    Finizio, M
    Von Hoff, DD
    Rowinsky, EK
    CLINICAL CANCER RESEARCH, 1999, 5 (02) : 299 - 308
  • [38] A phase I study of Triapine® in combination with doxorubicin in patients with advanced solid tumors
    Schelman, William R.
    Morgan-Meadows, Sherry
    Marnocha, Rebecca
    Lee, Fred
    Eickhoff, Jens
    Huang, Wei
    Pomplun, Marcia
    Jiang, Zhisheng
    Alberti, Dona
    Kolesar, Jill M.
    Ivy, Percy
    Wilding, George
    Traynor, Anne M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (06) : 1147 - 1156
  • [39] Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors
    Pronk, LC
    Schellens, JHM
    Planting, AST
    vandenBent, MJ
    Hilkens, PHE
    vanderBurg, MEL
    deBoerDennert, M
    Ma, J
    Blanc, C
    Harteveld, M
    Bruno, R
    Stoter, G
    Verweij, J
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 1071 - 1079
  • [40] A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors
    Lam, Elaine T.
    O'Bryant, Cindy L.
    Basche, Michele
    Gustafson, Daniel L.
    Serkova, Natalie
    Baron, Anna
    Holden, Scott N.
    Dancey, Janet
    Eckhardt, S. Gail
    Gore, Lia
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (12) : 3685 - 3694
12345